Insider · CIK 0001296996

Corcoran Andrea

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001296996

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-11	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+60K sh	$1.24	+$74.4K	823,576
2026-03-11	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	+60K sh	—	—	0
2026-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−10.5K sh	—	—	0
2026-01-31	AVIRAtea Pharmaceuticals, Inc.F Tax Payment	See Remarks	FTax Payment	−16.1K sh	$4.24	−$68.3K	763,576
2026-01-31	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+54.9K sh	—	—	779,680
2026-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−44.4K sh	—	—	0
2026-01-31	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+180K sh	—	—	180,000
2025-01-31	AVIRAtea Pharmaceuticals, Inc.A Award	See Remarks	AAward	+10.5K sh	—	—	733,409
2025-01-31	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+44.4K sh	—	—	722,909
2025-01-31	AVIRAtea Pharmaceuticals, Inc.F Tax Payment	See Remarks	FTax Payment	−16.1K sh	$3.06	−$49.3K	717,307
2025-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−44.4K sh	—	—	44,366
2025-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+10.5K sh	—	—	10,500
2025-01-31	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000
2024-02-01	AVIRAtea Pharmaceuticals, Inc.S Sale	See Remarks	SSale	−15.8K sh	$3.84	−$60.9K	670,208
2024-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−44.4K sh	—	—	88,733
2024-01-31	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+44.4K sh	—	—	686,051
2024-01-31	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000
2023-01-31	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+186K sh	—	—	186,300
2023-01-31	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+133K sh	—	—	133,100
2022-01-31	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+181K sh	—	—	181,000
2021-01-29	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+149K sh	—	—	148,850
2020-11-03	AVIRAtea Pharmaceuticals, Inc. · Series B Convertible Preferred StockC Conversion	See Remarks	CConversion	−33K sh	—	—	0
2020-11-03	AVIRAtea Pharmaceuticals, Inc.C Conversion	See Remarks	CConversion	+133K sh	—	—	633,004
2020-11-03	AVIRAtea Pharmaceuticals, Inc. · Series A Convertible Preferred StockC Conversion	See Remarks	CConversion	−100K sh	—	—	0
2005-02-28	IDENIX PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Exec. VP, Legal and Admin.	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 134
Corcoran Andrea0001193125-26-106547
SEC(opens sec.gov)
Feb 34
Corcoran Andrea0001193125-26-036269
SEC(opens sec.gov)
Feb 44
Corcoran Andrea0000950170-25-013849
SEC(opens sec.gov)
Feb 24
Corcoran Andrea0000950170-24-010973
SEC(opens sec.gov)
Feb 24
Corcoran Andrea0000899243-23-003607
SEC(opens sec.gov)
Feb 24
Corcoran Andrea0000899243-22-004184
SEC(opens sec.gov)

Companies

Address

225 FRANKLIN STREET SUITE 2100

BOSTON, MA, 02110